Stanford University
Showing 17,641-17,660 of 37,023 Results
-
Anson M. Lee, MD
Associate Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)
BioDr. Anson M. Lee is a board-certified, fellowship-trained cardiothoracic surgeon with Stanford Health Care. He is also an associate professor in the Department of Cardiothoracic Surgery, Division of Adult Cardiac Surgery at Stanford University School of Medicine.
Dr. Lee specializes in treating all types of heart disease, such as blocked arteries, structural and valve issues, and aortic conditions. He has a special interest in treating abnormal heart rhythms (arrhythmias) and performing advanced procedures, such as video-assisted thoracoscopic hybrid ablation for difficult-to-treat atrial fibrillation. He uses minimally invasive techniques whenever possible to reduce risk and ease recovery for his patients.
In addition to patient care, Dr. Lee is a dedicated heart researcher. His recent studies have focused on optimizing treatment for atrial fibrillation, heart and lung transplantation, and valve disease, as well as improving organ preservation for lung transplantation. He is one of only a few cardiothoracic surgeons in the world publishing research on hybrid ablation and has built a leading hybrid ablation center in collaboration with Stanford Medicine electrophysiologists.
Dr. Lee has published his findings in leading medical journals, such as The Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery. He participates in drafting clinical guidelines and currently serves on the Cardiac Clinical Practice Standards Committee of the American Association for Thoracic Surgery (AATS). He has also written several book chapters on cardiac surgery techniques, complications, and innovations. He regularly shares his research and expertise around the world, from presenting at the American Heart Association (AHA) Scientific Sessions to speaking at the AATS Foundation programs and symposiums in Thailand and China.
Dr. Lee is a member of the prestigious AATS. He is also a member of the AHA and the Society of Thoracic Surgeons. -
Anthony Lee
Executive Assistant 1, SoM - Senior Associate Dean Research Operations
BioExecutive Assistant, School of Medicine: Office of the Senior Associate Dean of Research- Dr. Ruth O'Hara
-
Bomi Lee
Assistant Professor of Pediatrics (Gastroenterology, Hepatology, and Nutrition)
Current Research and Scholarly InterestsMy lab is dedicated to unraveling the complexities of the immune microenvironment and its role in the pathogenesis of pancreatic diseases, such as pancreatitis and pancreatic cancer. By leveraging cutting-edge technology, innovative experimental and genetic animal models, as well as human specimens from donors, we aim to identify novel immune markers and potential therapeutic targets. Our goal is to advance the understanding of immune cells and their contributions to these diseases and to transl
-
Byrne Lee, MD FACS
Clinical Professor, Surgery - General Surgery
BioDr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.
Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.
Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.
